IP Library Granted Patent US 8,160,710
Granted Patent B2
US 8,160,710 · App. 11/775,638 · Granted Apr 17, 2012

Systems and methods for implanting tissue stimulation electrodes in the pelvic region

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,160,710
App. No.
11/775,638
Granted
Apr 17, 2012
Kind
B2
Abstract

Implantable medical devices to relieve problems associated with incontinence and related pelvic disorders and methods of implanting same are disclosed. Stimulation leads for placement in the pelvic floor have fixation mechanisms for stabilization of the stimulation electrodes to inhibit dislodgement from a selected stimulation site. In certain embodiments, the fixation mechanisms encourage fibrosis about the lead to chronically stabilize the position of the stimulation lead and/or stimulation electrode(s). In certain embodiments, the fixation mechanisms are isolated from body tissue during routing of the stimulation lead through a tissue pathway and then exposed to body tissue to encourage fibrosis.

Claims (19)

1. A stimulation lead assembly for placement in the pelvic floor and adapted to be coupled to an implantable pulse generator to deliver stimulation to selected stimulation sites comprising:

a first stimulation lead comprising:

a first elongated lead body extending between a first lead body proximal end and a first lead body distal end comprising a first insulating sheath and at least one electrical conductor within the first insulating sheath;

a first proximal connector assembly having at least one lead connector element at the first lead body proximal end coupled to a proximal end of the electrical conductor;

a first stimulation electrode at the first lead body distal end coupled to a distal end of the electrical conductor; and

a first fixation mechanism extending along a portion of the lead body coupled to the first insulating sheath and extending laterally away from the lead body, the fixation mechanism formed of a material encouraging tissue ingrowth along the length of the portion of the lead body to stabilize the stimulation electrode at the stimulation site; and

a second stimulation lead comprising:

a second elongated lead body extending between a second lead body proximal end and a second lead body distal end comprising a second insulating sheath and at least one electrical conductor within the second insulating sheath;

a second proximal connector assembly having at least one lead connector element at the second lead body proximal end coupled to a proximal end of the electrical conductor;

a second stimulation electrode at the second lead body distal end coupled to a distal end of the electrical conductor; and

a second fixation mechanism extending along a portion of the second lead body coupled to the second insulating sheath and extending laterally away from the second lead body, the second fixation mechanism formed of a material encouraging tissue ingrowth along the length of the portion of the second lead body to stabilize the stimulation electrode at the stimulation site; and

an interconnecting portion coupled to the first and second lead body distal ends.

2. The stimulation lead assembly of claim 1 , wherein the interconnecting portion comprises a segment of lead body extending between the first and second stimulation electrodes.

3. The stimulation lead assembly of claim 2 , wherein the first and second fixation mechanisms are between the first and second stimulation electrodes.

4. The stimulation lead of claim 3 , wherein the first and second fixation mechanisms comprises a sheet or tube of porous mesh having a mesh length and mesh width extending along the lead body.

5. The stimulation lead assembly of claim 1 , wherein the interconnecting portion comprises an extension of the first and second fixation mechanisms between the first and second stimulation electrodes.

6. The stimulation lead of claim 5 , wherein the first and second fixation mechanisms comprises a sheet or tube of porous mesh having a mesh length and mesh width respectively extending along the first and second elongated lead bodies.

7. The stimulation lead of claim 1 , further comprising first and second protective sheath assemblies enclosing the respective first and second stimulation lead bodies and the at least portions of the first and second fixation mechanisms adapted to facilitate passage of the stimulation lead assembly through a tissue pathway.

8. The stimulation lead assembly of claim 1 , wherein the first and second stimulation mechanisms each comprise a sheet of porous mesh, which is biased to maintain a substantially planar shape.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0607. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2007
From: BUYSMAN, JOHN JASON; LUND, ROBERT E.; MUJWID, JAMES R.; GOHMAN, JAMES A.
To: AMS RESEARCH CORPORATION
Reel/Frame 019583/0885 →